IOVA
Iovance Biotherapeutics, Inc.Healthcare$3.43
◆ Neutral
Mkt Cap: $1.41B|Float: 353.4M|SI: 32.6%|DTC: 5.2
Data as of market close Apr 2, 2026
IV Rank
5
IV Pctl
11%
HV 20d
92.0%
52W Range
$2-$6
ATR(14)
$0.25
Exp. Move
±7.3%
P/C Ratio
0.28
Earnings
May 7
GEX Positive
DEX Long
Net Put Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
IOVA Key Options Data
- IV Rank
- 5.4%
- Total GEX
- $0.00B
- Total DEX
- $7.4M
- Max Pain
- $3.00
- Expected Move
- ±7.3%
- Put/Call OI
- 0.28
- Net Premium
- $-0.0M
- Spot Price
- $3.43
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$0.25 | ±7.3% | $3.18 | $3.68 |
| 2026-04-17 | 15 | ±$0.50 | ±14.6% | $2.93 | $3.93 |
| 2026-04-24 | 22 | ±$2.67 | ±78.0% | $0.76 | $6.11 |
| 2026-05-01 | 29 | ±$3.10 | ±90.4% | $0.33 | $6.53 |
| 2026-05-08 | 36 | ±$2.50 | ±72.9% | $0.93 | $5.93 |
| 2026-05-15 | 43 | ±$1.60 | ±46.6% | $1.83 | $5.03 |
Explore IOVA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.